Analysis of Monocytic and Granulocytic Myeloid-Derived Suppressor Cells Subsets in Patients with Hepatitis C Virus Infection and Their Clinical Significance

Table 1

Basic characteristics of subjects.

Index	HCV patients; ()	CHC patients; ()	Hepatitis C cirrhosis; ()	Healthy control; ()
Sex; (male/female)	45/23	34/22	11/1	7/8
Age; (years, )	42.66 ± 13.17	41.20 ± 13.40	49.33 ± 9.89	30.30 ± 5.40
HCV RNA; (Iog IU/mL, mean ± SE)	5.847 ± 0.122	6.017 ± 0.132	5.053 ± 0.313	NA
HCV genotype
1b		20 (29.4%)		NA
6a		37 (54.4%)		NA
others		11 (16.2%)		NA
AST; (U/L, mean ± SE)	72.71 ± 6.29	65.18 ± 5.57	107.83 ± 22.44	18.60 ± 6.68
ALT; (U/L, mean ± SE)	82.96 ± 6.89	84.64 ± 7.29	75.08 ± 19.75	23.2 ± 5.78

NA: not applicable.